pSivida Corp (PSDV) Announces UK's National Institute for Clinical Excellence (NICE) Says Yes to ILUVIEN® in Some Patients With Diabetic Macular Edema in New Draft Guidance
6/14/2013 10:26:05 AM
More...
|
pSivida Corp (PSDV) Announces Tech Evaluation Agreement With Leading Global Pharmaceutical Company
5/29/2013 10:19:11 AM
More...
|
pSivida Corp (PSDV) Reports Third Quarter Fiscal Year 2013 Results
5/14/2013 8:13:52 AM
More...
|
pSivida Corp (PSDV) Reports Third Quarter Fiscal Year 2013 Results
5/14/2013 7:32:56 AM
More...
|
pSivida Corp (PSDV) Announces Commercial Launch of ILUVIEN® in Germany With First Patient Treated
5/8/2013 11:17:32 AM
More...
|
pSivida Corp (PSDV) Announces Third Quarter 2013 Financial Results Release Date and Conference Call Information
5/7/2013 7:57:55 AM
More...
|
pSivida Corp (PSDV) Announces Tech Evaluation Agreement With Leading Global Pharmaceutical Company
4/4/2013 11:56:24 AM
More...
|
pSivida Corp (PSDV) Reports on Resubmission to FDA of NDA for ILUVIEN® for Chronic Diabetic Macular Edema
4/1/2013 9:14:14 AM
More...
|
pSivida Corp (PSDV) Reports Updates on ILUVIEN® for Planned Resubmission to FDA and European Launch
3/22/2013 9:40:31 AM
More...
|
pSivida Corp (PSDV) Reports Second Quarter Fiscal Year 2013 Results
2/7/2013 6:37:38 AM
More...
|
|